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Malignant catarrhal fever (MCF) is a lymphoproliferative and inflammatory syndrome 
affecting primarily ruminant species.  The disease, which is often fatal, is most often 
described as affecting bovids and cervids.  No vaccines are available for prevention of 
MCFV infection.  The primary method to control spread of disease is to prevent contact 
between carriers and clinically susceptible species.  There is no known method to 
control infection of malignant catarrhal fever virus-white-tailed deer variant (MCFV-
WTD), as the carrier animal of this virus is unknown.   
To determine the prevalence of malignant catarrhal fever viruses in Tennessee 
ruminant populations, blood and/or lymph node samples were collected from farms, 
animal processing and disposal facilities, and hunter check-in stations from 2006-2008 
from several species of animals including cervids, cattle, and goats.  Strain-specific real 
time PCR was developed to detect ovine herpesvirus-2 (OvHV-2), caprine herpesvirus-
2 (CpHV-2), and MCFV-WTD DNA.  MCFV DNA was detected in all species of 
ruminants sampled.  Although disease related to infection with MCFV-WTD and CpHV-2 
has not been reported in Tennessee cattle or cervid populations, MCFV-WTD DNA was 
detected in 3 percent of cervid samples, and MCFV-WTD and CpHV-2 DNA was 
detected in 27 and 3 percent respectively of cattle samples from animal disposal 
facilities that process dead or debilitated animals. One hunter harvested deer (n=781) 
and 25 cattle (n=165) tested from animal disposal facilities were positive for OvHV-2 
DNA.   
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  This study demonstrated that healthy cattle and cervids can be infected with OvHV-2 
and MCFV-WTD without apparent disease, and dead or debilitated cattle were infected 
with OvHV-2, MCFV-WTD and CpHV-2 at a higher percentage than healthy herd 
animals.  Prevalence of CpHV-2 in Tennessee goat populations (7%) was significantly 
lower than reported in other goat populations (73%).  Low prevalence of CpHV-2 in 
Tennessee goat populations likely explains why no evidence of infection was found in 
cervids tested, and the low prevalence of CpHV-2 infection in dead or debilitated cattle 
compared to prevalence of infection with OvHV-2 and MCFV-WTD.  The discovery of 
infection in cattle with CpHV-2 and MCFV-WTD opens a new avenue of investigation 
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Chapter 1. Literature Review  
Malignant catarrhal fever – Introduction 
Malignant catarrhal fever (MCF) is a lymphoproliferative and inflammatory 
syndrome that primarily affects ruminant species.  The disease, which is often 
fatal, has been most often described as affecting bovids, cervids, and certain 
other susceptible ruminant species, but is also recognized in domestic pigs   
(Bedelian, 2007; OIE, 2004), and has been shown experimentally in rabbits 
(Rossiter et al., 1977, 1978).  Outbreaks of malignant catarrhal fever occur 
sporadically in all continents, and are attributed to large economic losses in 
domestic cattle, deer and bison herds (Berezowski et al., 2005; Brown and Bloss, 
1992; Dabak and Bulut, 2003; Hamilton, 1990; Li et al., 2008; Li et al., 2006; 
O'Toole et al., 2002).  Carrier animals have been identified and are believed to 
be the source of the disease in affected ruminants (Baxter et al., 1997; Li et al., 
1995; Plowright et al., 1960). There are many strains of virus that cause this 
disease in susceptible species, all of which belong to the Herpesviridae subfamily 
Gammaherpesviridae.  
Gammaherpesviruses 
The host range of the Gammaherpesvirinae subfamily is primarily limited to the 
family or orders to which the natural host belongs.  As with all viruses in the 
Herpesviridae family, their genomes are composed of linear double stranded 
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DNA.  The genomic DNA is packed into an icosohedral capsid which is 
embedded in a complex amorphous layer composed of several proteins called 
the tegument.  The entire structure is then enclosed by a glycoprotein containing 
lipid envelope (McGeoch et al., 2006).  Viruses in the Gammaherpesvirinae 
subfamily are usually specific for T or B lymphocytes, and latency is frequently 
established in lymphoid tissue (Fields et al., 2001).  Unlike alpha or beta herpes 
viruses, which seem to prefer lytic replication, gammaherpesviruses seem to 
favor the initial establishment of latency, while only a subset support lytic 
replication. The outcome of infections with the gammaherpesviruses depends not 
only on the virus but also the targeted animal.  In vivo, viruses in this subfamily 
have evolved with their reservoir hosts to actively protect their latently infected 
cells from being destroyed by the hosts’ immune response. Hosts have evolved 
to being infected and can transmit the viruses without showing symptoms of overt 
disease.  In animals not adapted to infection, such as in animals that did not co-
evolve with the virus, the development of lethal diseases such as malignant 
catarrhal fever or Kaposi’s sarcoma occurs (Ackermann, 2006).  In recent years 
many new gammaherpesviruses have been discovered and classified (McGeoch 
et al., 2005). 
The Gammaherpesvirinae subfamily has been traditionally divided into two 
genera: Lymphocryptovirus and Rhadinovirus (Fields et al., 2001).  The 
Lymphocryptovirus genus contains Epstein-Barr virus, and several other 
lymphocryptoviruses of primates.  The Rhadinovirus genus contains herpes- 
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viruses with hosts of many mammalian taxa.  Many of these viruses are of 
interest for medicine, veterinary medicine and biomedical research (Ackermann, 
2006).  There are many similarities between the two genomes.  Given these 
similarities and the restriction of lymphocrytoviruses to primates, it is proposed 
that lymphocryptoviruses may have evolved from an early primate rhadinovirus 
(Knipe et al., 2001).   
Gammaherpesviruses share many genes with limited or less obvious 
representation in the genomes of other herpes viruses.  These include genes that 
encode several immediate-early or early regulators of viral gene expression, an 
anti-apoptotic Bcl-2 homolog, and two integral membranes  (Knipe et al., 2001).   
Lymphocryptoviruses and rhadinoviruses have analogous, nonhomologous cis-
acting DNA sequences and transacting nuclear proteins necessary for 
persistence of the genomes as episomes in dividing cells.  The genomes of the 
lymphocryptoviruses and rhadinoviruses are much more related to each other 
than to other alpha or beta herpesviruses (Knipe et al., 2001).   
      Rhadinoviruses  
Most rhadinoviruses have cellular genes including dihydrofolate 
reductase, interferon regulator factors, G-protein coupled receptors, 
chemokine analogs, and a cyclin homolog in common.   These genes 
have not been detected in lymphocryptoviruses.  Unlike lymphocrypto-
viruses, rhadinoviruses are unable to immortalize B lymphocytes of 
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their natural host (Knipe et al., 2001).  Malignant Catarrhal fever 
viruses have traditionally been characterized as rhadinoviruses, 
although in recent years it has been proposed that a new genus, the 
Macaviruses, be established in the gammaherpesvirus subfamily, and 
that these viruses be placed in this family (McGeoch et al., 2006). 
Several viruses have been identified within the MCF virus group, four 
of which: alcelaphine herpesvirus-1, ovine herpesvirus-2, caprine 
herpesvirus-2, and malignant catarrhal fever virus white-tailed deer 
variant, are known to be pathogenic (Li et al., 2003a).   
Malignant Catarrhal Fever viruses as Interface diseases 
The interaction of domestic animals and wildlife is increasingly becoming an 
issue of concern with regard to the spread and emergence of infectious animal 
diseases.  Many important animal diseases cross-infect domestic animals and 
wildlife.  These animals may interface in places such as fence lines, shared 
habitat and ranges, common water sources, and live animal markets (Bengis et 
al., 2002) (Fevre et al., 2006).   
Many diseases are believed to be maintained in a region through infection of 
wildlife and domestic livestock.  There has been a long-standing conflict between 
livestock owners and animal health authorities, as well as wildlife 
conservationists, regarding controlling diseases of livestock associated with 
wildlife.  It is important to realize that where animals interface, transmission of 
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pathogens can be bidirectional: from wild to domestic animals, as well as 
domestic to wild animals (Bengis et al., 2002).  This bidirectional transmission of 
pathogens allows a disease agent to maintain a cycle within a region, making it 
difficult to eradicate or control.  The following malignant catarrhal fever viruses 
are most commonly associated with disease (Li et al., 2003a).  The cycle of 
disease transfer which occurs in the spread of these viruses relies upon the 
interface between domestic and wildlife species.      
Wildebeest-Associated Malignant Catarrhal Fever  
Etiology 
The virus known to cause malignant catarrhal fever in African 
bovids, alcelaphine herpesvirus-1, was first isolated from the 
leukocytes, spleen and lymph node suspensions of a blue 
wildebeest and described as being a herpesvirus in 1960 by 
Plowright and associates.  Initially designated Bovid Herpesvirus 3 
and believed to be similar to the betaherpesviruses (Roizman, 
1973) (Plowright et al., 1960), it was later discovered to most 
closely resemble viruses associated with the gammaherpesvirus 
family (Rossiter et al., 1983b), (Mushi and Rurangirwa, 1981).  
Malignant catarrhal fever had been shown to occur in cattle after 
close association with apparently healthy blue or black wildebeests 
(Daubney, 1936; Mettam, 1923), but prior to the work by Plowright 
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and associates, the etiologic agent had not been identified or 
isolated.  Having a method to obtain cell-free virus for use in 
experiments and development of diagnostics allowed for greater 
characterization of AlHV-1.  In additional to this, the entire genome 
was sequenced in 1997 (Ensser et al., 1997).   
Transmission of disease 
First believed only to exist as a cell-associated virus (Rweyemamu 
et al., 1974) (Plowright et al., 1960), it was later discovered that it 
could survive as cell free virus and be passed in this form to cattle 
by nasal secretions of wildebeest (Mushi et al., 1981).  It was also 
shown to be vertically transmitted to offspring transplacentally, 
when virus was isolated from the spleen of a fetus (Plowright et al., 
1960).  The main source of infection appears to be the wildebeest 
calf (Plowright, 1965), as virus has primarily been isolated from the 
ocular and nasal secretions of young wildebeest less than 3 
months, and virtually all animals are infected by age 4 months 
(Barnard et al., 1989a; Mushi et al., 1980).  Viral shedding in adults 
appears to be quite low, and occurs primarily during periods of 
stress or parturition (Barnard et al., 1989a; Rweyemamu et al., 
1974). Originally, fetal membranes and fluids were also believed to 
be a major source of infection to cattle, but virus was not isolated 
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from either material (Rossiter et al., 1983a).  It has been proposed 
that the membranes and fluids act as markers for pastureland 
which is heavily contaminated with malignant catarrhal fever virus 
from oculonasal secretions of wildebeest calves, therefore cattle 
should not be grazed at these locations (Rossiter et al., 1983a).   
In Kenya and Tanzania, wildebeest associated MCF occurs 
primarily during calving season ((Mushi and Rurangirwa, 1981), but 
in South Africa disease occurs most often during the late winter and 
early spring, when calves are 8-10 months old (Barnard et al., 
1989a).  In zoological parks sporadic cases of wildebeest 
associated MCF can appear throughout the year (Castro et al., 
1984; Hanichen et al., 1998).   
AlHV-1 is not transmitted from one clinically susceptible host to 
another via natural methods, as the virus secreted from non-host 
animals is cell-associated and therefore extremely labile (Mushi 
and Rurangirwa, 1981; Plowright, 1968).  As such, sick animals 
may be housed with healthy animals without fear of horizontal 
disease transmission (Plowright, 1965).  In some instances it is 
possible for cattle to transmit the virus to their offspring 




The length of incubation required to cause disease differs among 
species.  Reports from studies of experimental exposure estimate 
incubation to last from 9 to 60 days or longer (Hatkin, 1980; 
Plowright, 1968; Plowright et al., 1960).  In some instances, 
animals may recover from subclinical infection and the virus may 
recrudesce several months later (Heuschele et al., 1985).  The 
disease caused by AlHV-1 is characterized by corneal opacity, 
erosions on the oral epithelium, salivation, anorexia, a 
mucopurulent nasal discharge, and increased body temperature 
and is typically referred to as the “head and eye” form of MCF 
(Pierson et al., 1979).    Upon histologic examination, lympho- 
proliferation and generalized necrotizing vasculitis are the most 
commonly recognized signs (Metzler, 1991; Plowright, 1986).   
Sheep-Associated Malignant Catarrhal Fever  
Etiology 
For almost a century, sheep were believed to be the source of non-
wildebeest associated malignant catarrhal fever (Götze, 1930; 
Götze, 1929), but all attempts to isolate the causative agent were 
unsuccessful (Plowright, 1968; Selman et al., 1974).  Attempts to 
understand the etiology and epidemiology of the agent causing this 
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disease have therefore been less direct than methods used with 
wildebeest strains.  Lymphoblastoid cells have been propagated 
from cattle, deer and rabbits with sheep-associated malignant 
catarrhal fever (Reid et al., 1989; Reid et al., 1983; Schuller et al., 
1990).  One of these cell lines was used to construct a genomic 
library, and a clone from this library hybridized to cloned 
alcelaphine herpesvirus-1 DNA (Bridgen and Reid, 1991).  From 
this it was suggested that the viral agent of sheep-associated 
malignant catarrhal fever and alcelaphine herpesvirus-1 are closely 
related gammaherpesviruses and the virus was named ovine 
herpesvirus-2 (OvHV-2) (Roizmann et al., 1992).  Development of 
molecular techniques such as polymerase chain reaction has led to 
a greater understanding of OvHV-2.  In 2007 the entire genome 
was published (Hart et al., 2007).  Prior to that, inferences were 
made into how the virus reacted in a susceptible host based upon 
genes detected using molecular techniques (Coulter and Reid, 
2002; Thonur et al., 2006). 
Transmission of disease 
Virtually all domestic sheep are believed to be infected with ovine 
herpesvirus-2 (Baxter et al., 1997; Li et al., 1995).  Transmission of 
this virus occurs primarily from sheep after 3 months of age (Li et 
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al., 2001a).  The majority of viral shedding comes from adolescent 
lambs, age 6 to 9 months.  In general, the pattern of the 
appearance of viral DNA in nasal secretions occurred as a dramatic 
rise and subsequent fall within 24 to 36 hours.  In adolescent 
sheep, this can occur multiple times between the ages of 6 and 9 
months (Li et al., 2001a; Li et al., 2004).  The frequency of viral 
shedding declines past the age of 9 months (Li et al., 2001a).  
Shedding episodes in adult sheep occur much less frequently than 
shedding in adolescent lambs (Li et al., 2001a; Li et al., 2004).  
Unlike wildebeest associated malignant catarrhal fever, shedding of 
the virus does not seem to be associated with lambing, and no 
seasonal trend in viral shedding of adult sheep has been identified 
(Barnard et al., 1994; Li et al., 2001a). This suggests that the 
likelihood of transmission from an adult sheep to a susceptible host 
occurs at a relatively stable, albeit infrequent, rate.  Horizontal 
transfer between clinically ill cattle has not been shown in field 
observations and experimental data (Farquarson, 1946; Mare, 
1977; Plowright, 1990).   
Bali cattle, Asian swamp buffalo, the American bison, and deer 
species are reported to be more susceptible to disease caused by 
ovine herpesvirus-2 than Bos taurus and Bos indicus cattle species 
(Clark et al., 1970; Daniels et al., 1988; Hamilton, 1990; O'Toole et 
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al., 2002; Reid et al., 1987; Schultheiss et al., 2000).  In general, 
cattle are regarded to be less susceptible to disease caused by 
OvHV-2 than AlHV-1 (Loken et al., 2009). 
Pathology 
In most cases, disease in cattle caused by OvHV-2 is virtually 
indistinguishable from the syndrome produced from infection with 
AlHV-1.  Skin lesions occur more often in cattle and deer infected 
with the OvHV-2 strain than with AlHV-1 strain (Plowright, 1990).    
In deer, the syndrome appears to be peracute or acute, and 
animals succumb within 12 hours of onset of elevated temperature, 
mild diarrhea and inappetence without developing the characteristic 
signs of the disease (Reid, 1991), although some deer have 
developed acute haemorrhagic enteritis followed rapidly by death 
(Wilson et al., 1983).  Bison appear to be one of the most highly 
susceptible animals to disease when infected with OvHV-2.  Clinical 
onset of disease appears to be acute, with death coming within 1-3 
days of onset (O'Toole et al., 2002), although chronic cases do 
occur (Schultheiss et al., 1998).  Mortality in exposed bison herds is 
usually quite high (Schultheiss et al., 2000), although it has been 
shown definitively that bison do not spread virus to herdmates, as 
animals in an outbreak exposed prior to being added to an existing 
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herd of bison were the only animals exhibiting morbidity, even when 
51% of animals succumbed to disease (n=825/1610)  (Li et al., 
2006).  Goats can be infected with OvHV-2 (Li et al., 2001b), but 
disease associated with infection has not been reported. 
Goat-Associated Malignant Catarrhal Fever  
Etiology 
In recent years, goats have been believed to be a source of 
malignant catarrhal fever virus where sheep and wildebeest were 
not present, but the agent of infection was believed to be OvHV-2 
(Li et al., 1996; Wiyono et al., 1994).  In 2001, a study was 
published by Li and coworkers in which a novel gammaherpesvirus 
in domestic goats was identified, and the two viruses reported 
appear to be the same (Li et al., 2001b).  This virus was identified 
when OvHV-2-specific PCR failed to detect viral DNA in MCFV 
seropositive goats (antibody detected utilizing the CI-ELISA).  
Amplification product generated by degenerative primer PCR (Li et 
al., 2000) was analyzed and determined to be 71% identical to 
OvHV-2, 67% identical to AlHV-1, and 73% identical to MCFV-
WTD.  Based upon this information, the virus was characterized as 
a new member of the MCF group of viruses and designated caprine 
herpesvirus-2.  At the same time as the Li study, Chmielewicz and 
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associates detected a herpesvirus in an apparently healthy pig, and 
the source of this virus was determined to be a goat housed with 
the animal.  Upon analysis, it was observed that this virus also had 
high identity with OvHV-2 and AlHV-2, and was also characterized 
as a gammaherpesvirus and designated caprine herpesvirus-2 
(Chmielewicz et al., 2001).  The two viruses, which were 
characterized at the same time, appear to be the same.      
Transmission of disease 
The transmission pattern in goats of the virus appear to be similar 
to that of OvHV-2 in sheep, as kids separated from the herd at one 
week of age did not become infected with the virus, and adult goats 
were susceptible to CpHV-2 (Li et al., 2005).   
Pathology 
To date disease associated with infection of CpHV-2 has only been 
documented in cervid species, including white-tailed deer, sika 
deer, roe deer and moose (Chen et al., 2007; Crawford et al., 2002; 
Keel et al., 2003; Li et al., 2003b; Vikoren et al., 2006).   Symptoms 
in susceptible animals are most commonly reported to be chronic 
weight loss, as well as mural folliculitis (mural pattern of 
inflammation of the hair follicle), dermatitis, and alopecia (Crawford 
et al., 2002).   Upon histological examination the typical lesions 
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associated with the malignant catarrhal fever viruses are seen 
(lymphoproliferation and generalized necrotizing vasculitis) (Chen 
et al., 2007; Crawford et al., 2002).    
Malignant Catarrhal Fever Affecting the White-Tailed Deer  
Etiology 
First described by Li and associates in 2000, malignant catarrhal 
fever virus white-tailed deer variant (MCFV-WTD) was the third 
virus attributed to the pathogenic group of gammaherpesviruses.  It 
was detected when deer exhibiting clinical signs of the MCF 
syndrome as well as antibodies to a conserved epitope among 
MCF viruses did not test positive for either OvHV-2 or AlHV-1 by 
strain specific PCR.  Degenerative primers specific to a conserved 
region of the DNA polymerase gene were then utilized, and 
amplification product occurred (Li et al., 2000).  When this product 
was analyzed, it was found genetically to exhibit 82% identity to 
OvHV-2 and 71% identity to AlHV-1 (Kleiboeker et al., 2002; Li et 
al., 2000).  All animals reported to have been infected with this virus 
were maintained in captive herds.  The original reservoir host of this 
virus is unknown, although it is estimated to be a close relative of 
the sheep or goat (O'Toole and Li, 2008). 
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Transmission of disease 
Based upon reports, cases of MCF associated with white-tailed 
deer occur in late fall or early winter, typically a time of high stress 
(Kleiboeker et al., 2002; Li et al., 2000).  The mode of transmission 
of this virus is unknown, as the reservoir animal has not been 
identified (Kleiboeker et al., 2002; Li et al., 2000; O'Toole and Li, 
2008).   
Pathology 
In affected deer, MCFV-WTD causes the classic symptoms of MCF 
syndrome described previously in cattle, with the exception of 
corneal opacity (Li et al., 2000).        
Treatment, Control and Prevention of Disease  
Currently there is no reliable method to treat MCF syndrome in affected animals.  
Occasionally supportive care with fluids and treatment with steroids and 
antibiotics has been effective in helping animals recover, but this does not occur 
consistently (Heuschele et al., 1985; Milne and Reid, 1990; Penny, 1998).  
Whether treatment is actually effective in helping animals’ recovery is still not 
proven, as treatment has not been shown to increase recovery in animals.  There 
are also many reports of animals recovering without treatment (Hamilton, 1990; 
Kalunda et al., 1981; O'Toole et al., 1997).   
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The best method for controlling the spread of disease in susceptible hosts such 
as bison, deer, Bali cattle, water buffalo, and to a lesser extent, European breeds 
of cattle, is to prevent exposure to known carrier animals: wildebeest, sheep and 
goats.  It has been suggested that waiting until later in the day to graze cattle in 
wildebeest inhabited areas would greatly limit the exposure of cattle to AlHV-1, 
as virus is inactivated rapidly in sunlight (Rossiter et al., 1983a).  This would 
allow wildebeest and cattle to share the best grazing land, and still limit the 
amount of disease in cattle.  There is no reliable way to produce virus-free 
wildebeest calves, as some are infected transplacentally (Plowright et al., 1960), 
and virtually all animals in a herd are infected by 4 months of age (Barnard et al., 
1989a; Mushi et al., 1980).  A method to obtain virus-free sheep and goats has 
been shown (Cooley et al., 2008; Li et al., 2005; Li et al., 1998; Muller-Doblies et 
al., 2001).  This consists of removing lambs from a positive flock by the age of 
2.5 months.  Kids were removed at 1 month and remained virus free.  Derivation 
of virus free animals from MCFV positive females has important implications for 
disease control programs, especially in mixed species wildlife parks and 
zoological gardens. 
Attempts to develop a vaccine to prevent infections with  AlHV-1, have been 
made in the past without success (Plowright et al., 1975) .  Currently the only 
method of prevention available is proper management of susceptible species. 
17 
 
Impact of Malignant Catarrhal Fever Viruses 
There is a large variation in the impact that MCFV’s have, depending on strain of 
virus and type of animal infected.  Economic impact in Africa has been estimated 
to cause losses of up to 5-10% in domestic cattle herds (Barnard et al., 1989b; 
Bedelian, 2007; Plowright et al., 1975).  In areas adjacent to wildebeest calving 
zones, Massai pastoralists believe MCF to be the most important disease with 
the largest impact on domestic cattle production, and in other areas where 
wildebeest were less prominent, it remained the fourth most common disease. 
Percent drop in sale price per animal infected with MCF in Africa was estimated 
at 50% in 2003-2004 (Bedelian, 2007).  Several exotic species are also 
susceptible to AlHV-1, and losses in zoological gardens as well as in free-ranging 
African wildlife have been reported (Castro et al., 1984; Hamblin and Hedger, 
1984; Hatkin, 1980). 
Although economic losses related to sheep associated MCF have not been 
estimated, extremely high mortality rates have been reported in many herds of 
animals, especially deer and bison (Blood et al., 1961; Brown and Bloss, 1992; 
Clark et al., 1970; Hamilton, 1990; Li et al., 1999; Murray and Blood, 1961; 
O'Toole et al., 2002; Otter et al., 2002; Schultheiss et al., 2000; Tomkins et al., 
1997).  There have also been many reports of disease in free-ranging animals 
(Neimanis et al., 2009; Schultheiss et al., 2007; Vikoren et al., 2006). It is difficult 
to estimate the true losses of wildlife animals to sheep-associated MCF, as all 
cases are not recovered.  
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Losses in farmed and free-ranging cervids due to CpHV-2 have been reported 
and have been substantial in some cases (Chen et al., 2007; Vikoren et al., 
2006).  The symptoms of infection with CpHV-2 are not immediately detected 
(generally chronic weight loss and alopecia), thus the true impact of this disease 
may not be apparent, as it is most likely underreported.   
To date, MCF associated with white-tailed deer has only been reported in captive 
white-tailed deer, and losses were varied in the two reports (Kleiboeker et al., 
2002; Li et al., 2000).  After discovery of this virus in captive white-tailed deer in 
Missouri, a further survey of several deer samples from both captive and wild 
white-tailed deer did not reveal MCFV-WTD infection and presence of the virus is 
not considered to be widespread in Missouri (Kleiboeker et al., 2002).  A 2005 
survey of samples from hunter harvested free-ranging white-tailed deer in east 
Tennessee revealed a rate of infection greater than 30%, with assumed 
subclinical infection (unpublished data).  The impact of infection with MCFV-WTD 
in wild white-tailed deer is not yet understood.  
 Diagnostic Measures for MCF 
Virus isolation 
AlHV-1 
Plowright and associates first isolated AlHV-1 in cell culture 
((Plowright et al., 1960).  He was later able to obtain cell-free virus 
of an isolate (WC11) after 49 calf kidney transfers and a further 5 or 
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10 passages as cell-free fluids in calf-thyroid cells
 
(Plowright, 1968).  
After passage, it was still able to cause fatal MCF in cattle with a 
dose of 104 TCID50. This isolate is still utilized today for diagnostics, 
and was essential in determining virus characteristics.  Virus 
isolation is not very specific, as other viruses may grow in cell 
culture if the animal has a co-infection.  Sensitivity can also be low, 
as sample type and proper management are crucial for maintaining 
live virus until it can be cultured (Mushi et al., 1980). 
OvHV-2 
Lymphoblastoid cells infected with OvHV-2 have been propagated 
from cattle, deer and rabbits with sheep-associated malignant 
catarrhal fever (Reid et al., 1989; Reid et al., 1983; Schuller et al., 
1990), but cell-free virus has not yet been cultivated.       
Virus Neutralization Assay 
This assay was developed by Plowright in 1967, utilizing the WC11 virus 
isolate mentioned previously (Plowright, 1967).  The virus neutralization 
assay in use today still employs the AlHV-1 virus as the target of 
neutralization, as cell free virus has never been isolated from other strains.  
This assay works best for antibody against the alcelaphine group of 
herpesviruses, and is used primarily in studying the range and extent of 
natural gammaherpesvirus infections in wildlife, zoological gardens and, 
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occasionally sheep populations. The virus neutralization assay is not used 
as a diagnostic test in clinically affected animals, as these animals are not 
able to produce virus neutralizing antibody (OIE, 2008).  Animals with 
sheep-associated MCF do not produce virus neutralizing antibodies to 
AlHV-1 (Rossiter, 1983). 
 Serology 
Indirect Immunoflorescence assay (IFA)  
Although the IFA is not as specific as the virus neutralization assay, 
it is useful in detecting antibodies to several varieties of ‘early’ and 
‘late’ antigens in AIHV-1-infected cell monolayers.  These are 
antibodies that develop during the incubation period as well as 
during the clinical course of the disease.  This test is not very 
specific, as other herpesviruses such as bovine herpesvirus-4 and 
infectious bovine rhinotracheitis virus cross-react (Rossiter et al., 
1977).  This assay can  be utilized to detect sheep-associated MCF 
when this disease is suspected, but should be used in concert with 
another diagnostic method (OIE, 2008).    
Enzyme-Linked Immunosorbent Assay (ELISA) 
Many ELISA assays have been developed to detect antibody to 
MCFV’s (Fraser et al., 2006; Frolich et al., 1998; Wan et al., 1988).  
The most commonly accepted method of detecting antibody to 
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MCFV infection is the competitive inhibition ELISA (OIE, 2008).  
Developed in 1994, this assay was designed to detect antibody to 
OvHV-2 using a MAb (15-A) targeting an epitope on a complex of 
glycoproteins that appears to be conserved among all MCF viruses. 
The antibody was raised against the wildebeest strain of MCF from 
a Minnesota isolate very similar to the WC11 strain (Hamdy, 1978; 
Li et al., 1994). Antibody to four MCFV’s has been detected: AlHV-
1,OvHV-2, CpHV-2 and MCFV-WTD, as well as one other very 
similar gammaherpesvirus: AlHV-2 (Li et al., 1994).  Originally an 
indirect CI-ELIZA which utilized enzyme labeled anti-mouse 
immunoglobuins for antibody detection, this test was reformatted as 
a direct CI-ELISA in 2001 to increase sensitivity (Li et al., 2001c). 
The MAb 15A was conjugated directly with an enzyme label and a 
method was developed to precoat and store antigen-containing 
plates at 4degrees C for long periods without degradation.  After 
modification, the sensitivity of this assay in cattle with clinical 
sheep-associated MCF approximates 95%, (80% in bison).  The 
specificity was also increased, and is estimated to be 94% when 
utilized with cattle, deer, and bison.  According to the OIE, the CI-
ELISA has the advantage of being faster and more efficient than 
the IFA (OIE, 2008). In general the CI-ELISA method is frequently 
shown to be more sensitive than the IFA in detection of herpesviral 
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DNA (Nielsen and Vestergaard, 1996).  Although this assay 
appears to be highly sensitive in most clinically affected animals, it 
has not been validated for use in detecting latent infection in non-
diseased animals. 
PCR 
Nested Degenerative Herpesvirus PCR 
First developed in 1996, this assay allowed for detection of many 
new gammaherpesviruses.  Primary and secondary PCRs are 
performed with degenerate PCR primers targeted to a highly 
conserved region within the herpesviral DNA-directed DNA 
polymerase gene, using a nested format. This assay allows for the 
determination of partial herpesviral sequences for which no data 
have previously been reported.  This is a sensitive (as little as 10 
copies of DNA polymerase template per 100ng of DNA is 
detectable) and broadly applicable approach to the detection and 
identification of previously characterized herpesviruses present in 
human and animal tissues (VanDevanter et al., 1996).  Adaptations 
of this PCR have been used to characterize new 
gammaherpesviruses in the MCF family (Kleiboeker et al., 2002; Li 
et al., 2000).  The disadvantage of utilizing this assay for 
diagnostics is that it is quite time-consumptive, as well as 
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expensive to run.  As the assay is not strain specific, product needs 
to be sequenced in order to correctly identify strains, which requires 
cloning and/or further processing.  Also, several concentrations of 
DNA, as well as variations in the amount of enzymes and 
chemicals used must be evaluated in order to detect all virus 
positive samples, as the addition of reagents such as dimethyl 
sulfoxide (DMSO) has been shown to increase relative sensitivity in 
detection of some viruses, but decrease relative sensitivity of 
detection of others.  
Strain specific PCR 
Once a virus has been identified and genes have been 
characterized, strain specific assays have been developed for use 
in virus identification.  These include traditional PCR assays (Baxter 
et al., 1993; Crawford et al., 1999; Li et al., 2001a; Li et al., 1995; 
Murphy et al., 1994; Wiyono et al., 1994), as well as real-time PCR 
assays (Cunha et al., 2009; Traul et al., 2007).  The development of 
real-time strain specific assays for the detection of viral antigen in 
diseased animals has increased efficiency by increasing specificity, 
and has shortened the amount of time it takes to diagnose an 
animal with infection. Most recently a real-time PCR assay was 
developed to detect and differentiate malignant catarrhal fever 
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viruses in clinical samples (Cunha et al., 2009).  In this assay, one 
pair of primers is utilized with fluorescently labeled probes specific 
for OvHV-2, CpHV-2, MCFV-WTD, MCFV-ibex, and AlHV-1 to 
identify these pathogenic MCFVs in clinical samples. All probes in 
this assay were able to detect as few as 50 copies of the specific 
viral DNA per reaction.  Considering all five MCFV together, the 
multiplex real-time PCR assay has 97.2% sensitivity.  When 
samples positive for other herpesviruses were analyzed, 
amplification did not occur, therefore this assay appears to be very 
specific for the viruses it was developed to detect.  This assay 
should improve the length of time it takes to identify the strain of 
MCFV generating disease in an animal, but has not been validated 
for use in detecting latently infected animals. 
A full description of the currently accepted diagnostic techniques for malignant 
catarrhal fever viruses can be found in the OIE Manual of Diagnostic Tests and 
Vaccines for Terrestrial Animals (OIE, 2008).  
 
Malignant Catarrhal Fever viruses in Tennessee 
Background information 
The occurrence of malignant catarrhal fever in Tennessee ruminant 
populations has not been investigated and quantified, but has been 
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assumed to occur sporadically and to be most commonly associated with 
exposure to infected sheep.  In 2005, a bison was presented to the 
University of Tennessee College of Veterinary Medicine necropsy service.  
Based upon gross and histological examination, it was believed the animal 
had succumbed to an infection of malignant catarrhal fever virus.  
Diagnostics were performed by National Veterinary Services Laboratory 
(NVSL) in Fort Collins, CO.  Sheep-associated MCF was diagnosed by 
presence of OvHV-2 DNA.  The animal had not been exposed directly to 
any sheep, and there were no sheep located within a 5 mile radius of the 
farm.  Two additional cases of malignant catarrhal fever virus disease in 
local bison from intermingled livestock sources and 2 sheep-associated 
MCF affected cattle with no known exposure or proximity with sheep were 
then identified over the next six months. 
The source of the infection in the bison and cattle was unknown, therefore 
it was hypothesized that white-tailed deer in the area may have 
transmitted the disease to the animals.  Historically, deer have been 
suspected of being able to transmit OvHV-2 to cattle and bison (Imai et al., 
2001), although this has yet to be proven.  In the fall of 2005, an initial 
limited- survey of deer harvested in the region was undertaken.  The 
cELISA was used to identify potentially infected deer, and DNA was 
extracted from the sodium heparinized blood of antibody positive samples.  
Based on the cELISA results there appeared to be widespread, moderate 
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rate (32 %: 30/92) of wild white-tailed deer in at least 12 counties in the 
eastern and middle areas of Tennessee that possessed antibody to a 
conserved epitope of the MCF family, but none of the animals were 
positive for OvHV-2 DNA (unpublished data).  When additional tests were 
performed, it was determined that the antibody positive animals had been 
infected with the malignant catarrhal fever virus white-tailed deer variant 
(MCFV-WTD) (unpublished data).  
Tennessee is second in the United States only to Texas in numbers of 
meat goats produced, with over 100,000 animals (National Agriculture 
Statistics Service, 2002).  Due to the belief that CpHV-2 is endemic in 
domestic goats with infection rates similar to that of OvHV-2 in sheep (Li 
et al., 2005), as well as reports of serious disease in cervid species as a 
result of infection with this virus, (Crawford et al., 2002; Keel et al., 2003; 
Li et al., 2003b) we were prompted to investigate prevalence of CpHV-2 in 
goats and deer in the state of Tennessee. 
Project Objectives 
Based upon the prior experimental data, clinical information obtained by 
the necropsy and LACS services, and a review of the literature, we believe 
MCF viruses are present in an interface of ruminant species across the 
state of Tennessee.  We have developed several objectives to investigate 
the prevalence of MCFV’s in Tennessee ruminant populations. 
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 Objective 1: Determine the prevalence of MCFV’s in Tennessee deer 
 populations 
 Objective 2: Determine the presence and prevalence of CpHV-2 in 
 Tennessee goat herds 
 Objective 3: Determine if cattle have been infected with OvHV-2 and/or 
 other MCFV’s and if the prevalence of virus is higher in dead/debilitated 







Chapter 2. Malignant Catarrhal Fever virus-White Tailed Deer 
variant in Tennessee Wild and Domestic Cervid Populations 
Abstract  
For decades, malignant catarrhal fever viruses (MCFV’s) have been reported to 
cause disease in cervids.  Prevalence of MCFV’s in Tennessee deer populations 
has not been investigated previously, so blood and/or lymph node samples were 
obtained from wild white-tailed deer harvested in the 2006, 2007, and 2008 
Tennessee hunting seasons, as well from captive deer at local mixed species 
animal parks. Strain specific real-time polymerase chain reaction was performed 
to determine prevalence of infection with ovine herpesvirus-2, caprine 
herpesvirus-2, and malignant catarrhal fever virus white-tailed deer variant in 
individuals without apparent disease.  Overall, prevalence of MCFV’s in 
Tennessee cervids was less than 3%.  MCFV’s do not appear to be an issue of 
major concern for the health of Tennessee cervid populations, although these 
viruses are present in the deer population, and should be considered a health 
risk. 
Introduction 
Malignant catarrhal fever viruses have been reported to cause disease in several 
cervid species, and in farmed deer have been known to cause severe economic 
losses due to mortality (Brown and Bloss, 1992; Crawford et al., 2002; Heuschele 
et al., 1985; Imai et al., 2001; Keel et al., 2003; Kleiboeker et al., 2002; Klieforth 
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et al., 2002; Li et al., 2000; Li et al., 2003b; Reid, 1991; Reid et al., 1987; Reid et 
al., 1989; Schultheiss et al., 2007; Tomkins et al., 1997; Wilson et al., 1983).  
There have also been many reports of disease associated with OvHV-2 and 
CpHV-2 in free-ranging animals (Neimanis et al., 2009; Schultheiss et al., 2007; 
Vikoren et al., 2006). The population of free-ranging white-tailed deer in the state 
of Tennessee is estimated to exceed 900,000 animals.  This species is 
considered to be the most important big game mammal of the eastern U.S., and 
hunting related expenditures associated with white-tailed deer hunting have an 
economic impact exceeding $650,000,000 annually in Tennessee (TWRA, 2010). 
Clinical signs of MCF vary depending on the strain of virus the animal is infected 
with.  In deer, sheep-associated MCF appears to be peracute or acute, and 
animals are reported to succumb within 12 hours of onset of elevated 
temperature, mild diarrhea and inappetance, without developing the 
characteristic signs of the disease (Reid, 1991), although some deer have 
developed acute hemorrhagic enteritis followed rapidly by death (Wilson et al., 
1983). It is difficult to estimate the true losses of wildlife to sheep-associated 
MCF, as few cases are recovered.  
Losses in farmed and free-ranging cervids due to CpHV-2 have been reported 
and in some cases were substantial (Chen et al., 2007; Vikoren et al., 2006).  
The symptoms of infection with CpHV-2 are not easily detected (generally 
chronic weight loss and alopecia), thus the true impact of this disease may not be 
apparent, as it is most likely underreported.  Tennessee is second in the United 
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States only to Texas in numbers of meat goats produced, with over 100,000 
animals (National Agriculture Statistics Service, 2002).  Due to the belief that 
CpHV-2 is endemic in domestic goats with infection rates similar to that of rates 
of OvHV-2 in sheep (Li et al., 2005), as well as reports of serious disease in 
cervid species as a result of infection with this virus (Crawford et al., 2002; Keel 
et al., 2003; Li et al., 2003b), we were prompted to investigate prevalence of 
infection with CpHV-2 in deer in the state of Tennessee. 
First described by Li and associates in 2000, MCFV-WTD was the third virus 
attributed to the pathogenic group of gammaherpesviruses.  The original 
reservoir host of this virus is unknown, although it is estimated to be a close 
relative of the sheep or goat (O'Toole and Li, 2008).  Cases of MCF associated 
with white-tailed deer occur in late fall or early winter, typically a time of high 
stress (Kleiboeker et al., 2002; Li et al., 2000).  MCFV-WTD causes most of the 
classic symptoms of MCF syndrome described previously in cattle, (i. e., serous 
ocular discharge, anorexia, depression, conjunctivitis, and periocular and nasal 
epithelial erosions, although not corneal opacity) in white-tailed deer (Li et al., 
2000; O'Toole and Li, 2008). 
To date, MCF associated with white-tailed deer has only been reported in white-
tailed deer, and losses varied in the two reports (5 of 6 deer in one study, 1 deer 
each from 3 separate farms in another, where no other animals at the farms were 
affected)(Kleiboeker et al., 2002; Li et al., 2000).  A 2005 preliminary survey of 
samples from wild white-tailed deer in east Tennessee revealed a rate of 
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infection with MCFV-WTD greater than 30%, with assumed subclinical infection 
(Robert Donnell, personal communication).  The impact of infection with MCFV-
WTD in wild white-tailed deer is not yet understood, and in Tennessee has not 
been extensively investigated.  The objective of this study was to determine the 
prevalence of MCFV’s in Tennessee cervid populations, primarily white-tailed 
deer.  Although the most common method utilized to estimate prevalence of 
MCFV exposure in free-ranging wildlife has been the competitive inhibition 
enzyme linked immunosorbance assay (Frolich et al., 1998; Li et al., 1996; 
Zarnke et al., 2002), strain-specific real-time PCR was utilized in this study for 
detection of MCFV DNA.  Real-time PCR was utilized because it can be 
developed to detect specific strains of MCFV, and is less time and resource 
consumptive than traditional PCR and degenerative herpesviral consensus 
primer PCR methods.  Blood and lymph node samples were obtained from white-
tailed deer harvested in the 2006-2008 hunting seasons, as well as from cervids 
in local mixed species animal parks. 
Methods 
Sample Collection 
Samples were collected primarily at Tennessee Wildlife Resource Agency 
approved check-in stations during the 2006, 2007, and 2008 white-tailed 
deer hunting seasons (Table 2.1).  The permitted harvest of antlerless 
deer (deer with no antlers, or those with antlers less than 3 inches in 
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length) varied per county (in some counties as little as 5 per season, in 
others as many as 3 per day).  For bucks (any deer with at least one antler 
longer than 3 inches) the statewide limit allowed is 3 per season. All 
animals harvested must be >6 months of age.  In addition to check-in 
stations, wild-game processors were utilized to collect samples from 
hunter-harvested deer, and sampling packets were distributed to hunters.  
Blood and/or lymph nodes were obtained from every animal where 
possible.  The primary lymph node extracted was the inguinal lymph node, 
due to ease of access and decreased chance of meat contamination at 
this location.  Pooled blood was removed from the body cavity of field 
dressed animals when available.  Animals were considered to be in good 
health if they exhibited good body condition at the time of sampling.   
A small number of blood samples were obtained in 2008 from cervid 
species at two local mixed species parks.  Both parks contained several 
species of deer, goat and sheep, as well bison and exotic species 
(aoudad, zebra, ostrich, emu, etc).  Where live animals were utilized to 
obtain samples, animals were handled in a manner approved by the 
University of Tennessee Institute of Animal Use and Care committee.   
Locations of the sampled deer were categorized by Tennessee Wildlife 
Resource Agency Region (1-4) (Figure 2.1).  All blood samples were 
stored in vacutainer tubes containing heparin at 4 degrees C until further 
processing.  Lymph nodes were collected, placed in sterile plastic conical 
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tubes, and stored at -20 degrees C until further processing.  When 
necessary, some lymph node samples were stored in 10% buffered 
neutral formalin until further processing, as these samples were obtained 
from either hunter sampling packets or areas a considerable distance from 
the university (primarily Region 1 samples), and length of transit would 
have led to degradation of the sample. 
 
Table 2.1 Tennessee Wildlife Resource Agency Permanent Opening Dates for 
Deer Hunting 
Samples were collected at TWRA checking stations in November and December, but samples were 
collected at wild-game processing facilities throughout the hunting seasons (2006-2008).  Sample 
collection ended each year by December 24. Information obtained from the Tennessee Hunting and 
Trapping Guide (TWRA, 2009). 
 
Hunting Type Opening Date 
Deer/Archery Fourth Saturday in September 
Deer/Muzzleloader First Saturday in November 
Deer/Gun Saturday before Thanksgiving 









DNA was extracted from blood and/or tissue using the DNeasy 
blood and tissue kit according to the provided manufacture’s 
protocol (Qiagen, Valencia, CA).   
OvHV-2 and CpHV-2 
Real-time PCR was performed according to the following protocol:  
per each reaction: 2 microliters extracted DNA, 10 microliters 
Taqman Universal PCR master Mix (Applied Biosystems, Foster 
City, CA) 0.4 microliters Rox Reference Dye II (Madison, WI), 0.9 
microliters each of forward and reverse primer, 0.25 microliter 
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Probe, and 7.55 microliters DNase RNase free water.  The reaction 
protocol is as follows: 50 degrees C for 30 seconds, 90 degrees C 
for 10 minutes, then 42 cycles of: 95 degrees C for 15 seconds, 
OvHV-2:61 degrees C for 1 minute /CpHV-2: 50 degrees C for 1 
minute, and 72 degrees C for 30 seconds.  Samples were 
considered positive if amplification occurred above the baseline 
prior to cycle 40.   
OvHV-2 Primer and Probe set: F primer sequence: 5’- TGG TAG 
GAG CAG GCT ACC GT-3’ R primer sequence: 5’-ATC ATG CTG 
ACC CCT TGC AG-3’ Probe (P: 5’- 56-FAM/TCC ACG CCG TCC 
GCA TAA GA/3BHQ_1-3’) (IDT, Coralville, PA), 
CpHV-2 Primer and Probe set: F primer sequence: 5’- CAC TAC 
AAC ATC CTG TCC TT-3’ R primer sequence: 5’- AGG GTA AAG 
AAT GCA TAC AG -3’ Probe: 5’- 56-FAM/ AGA CGA AGA CAT 
AAT TAT CCA GAT ATC /3BHQ_1-3’ (IDT, Coralville, PA). 
OvHV-2 and CpHV-2 primer and probe sets were developed 
previously in the lab for use with another real-time PCR apparatus 
(personal communication).  Temperatures were adjusted to 




To develop an assay mix to identify MCFV-WTD in cervids, the 
program File Builder v 3.1 was utilized (Applied Biosystems). The 
MCFV-WTD DNA polymerase gene (partial cds) sequence 
obtained in GenBank, accession number: AF387516 was imported, 
and a section not found in OvHV-2, AlHV-1 or CpHV-2 was 
designated for use within the probe.  Areas within the sequence (> 
12 base pairs) similar to human, mouse, bovine, and ovine DNA 
were eliminated from the segment.  This segment was then 
submitted to Applied Biosystems for final primer and probe design.  
The StepOne® unit from Applied Biosystems was utilized for real-
time PCR.   
Real-time PCR was performed according to the following protocol:  
per each reaction: 2 microliters extracted DNA, 10 microliters 
Taqman Universal PCR master Mix (Applied Biosystems, Foster 
City, CA) 1 microliter of custom Taqman gene expression assay 
mix (Forward primer sequence: 5’- AGC AAA TAT GCC CAA CCC 
AGA TTA T-3’; Reverse primer sequence: 5’- GAG GCT AGC TTG 
TCG CTG AA-3’; Probe: 5’- 56-FAM/ AAT CGC CCC ACA CTA 
AC/3BHQ_1-3’) (Applied Biosystems, Foster, CA), and 7 microliters 
DNase RNase free water.  The reaction protocol is as follows: 50 
degrees C for 2 minutes, 90 degrees C for 10 minutes, then 40 
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cycles of: 95 degrees C for 15 seconds, 60 degrees C for 1 minute.  
As this was a new assay, samples from a sheep infected with 
OvHV-2 and a deer infected with CpHV-2 (provided by Hong Li of 
the USDA-ARS) were utilized to confirm specificity.  In addition, 
plasmid DNA containing a portion of the MCFV-WTD DNA 
polymerase gene obtained from Stephen Kleiboecher (formerly of 
the University of Missouri), as well as DNA from a deer that had 
died from MCFV-WTD (provided by Hong Li of the USDA-ARS) 
were utilized as positive controls. Finally, samples exhibiting 
amplification above the baseline prior to cycle 40 were rerun in 
duplicate and these products were sequenced at the University of 
Tennessee Molecular Biology Resource Facility to confirm 
presence of MCFV-WTD DNA. 
Results 
Sample Collection 
Blood and lymph node samples were collected from check-in stations, 
farms, and processing facilities throughout the 4 TWRA regions.  A list of 
assayed samples per region is given in Table 2.2.   
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MCFV-WTD Assay Development and Prevalence 
The assay mix and protocol provided by Applied Biosystems worked well 
to detect MCFV-WTD DNA polymerase gene DNA.  Both samples utilized 
as positive controls were detected by the assay.  The relative sensitivity of 
the assay (based upon serial dilutions of a known copy number of the 
MCFV-WTD plasmid DNA positive control) showed that the probe was 
able to detect as few as 4 copies of viral DNA per reaction (data not 
shown). Also, the probe was highly specific, with no cross-reactivity 
detected with OvHV-2 or CpHV-2 positive samples.  
Overall, prevalence of MCFV-WTD DNA was greater than any other 
MCFV in Tennessee cervids, at 2.9% (23/784), although this was much 
lower than preliminary data from the 2005 season (30 %).  The highest 
prevalence (3.9%) was found in Region 4 (which was the region utilized 
for sample collection in the preliminary 2005 study.  The lowest 
prevalence of MCFV-WTD (0.6%) was found in Region 1 (Table 2.3).  All 
but one of the 23 positive samples were obtained from deer in the 2006 
hunting season. 
OvHV-2 Prevalence 
Prevalence of OvHV-2 DNA in samples was quite low (0.1%), with only 
one deer testing positive of 781 sampled and tested.  The only region with 




There was no CpHV-2 DNA detected in any of 724 animals sampled and 
tested (Table 2.3). 
 
Table 2.2 Samples Taken per TWRA Region and Assay Performed 
Blood and/or lymph node samples were obtained from Tennessee cervids from 2006-2008, primarily 
during the Tennessee deer hunting seasons.  Samples are from white-tailed unless otherwise indicated. 
 
Region Assay 







1 MCFV-WTD 69 30 56 155 
 
OvHV-2 87 18 68 173 
 
CpHV-2 67 38 62 167 
      
2 MCFV-WTD 17 19 80 116 
 
OvHV-2 16 19 73 108 
 
CpHV-2 9 3 59 71 
      
3 MCFV-WTD 38 48 93 179 
 
OvHV-2 40 42 96 178 
 
CpHV-2 30 48 90 168 
      
4 MCFV-WTD 169 20* 145 334 
 
OvHV-2 162 12# 148 322 
 
CpHV-2 101 14* 203 318 
* includes 4 sika deer, 2 Elk, and 1 Axis deer 
   
# includes 1 Axis deer 





Table 2.3 Prevalence of MCFV per TWRA region 
Strain Specific real-time polymerase chain reaction was performed on samples obtained primarily in the 
2006, 2007, and 2008 Deer hunting seasons.   
 
 
MCFV DNA Present 
Region MCFV-WTD OvHV-2 CpHv-2 
 
Pos/Tested (%) Pos/Tested (%) Pos/Tested (%) 
1 1/155 (0.6) 0/173 0/167 
2 4/116 (3.5) 0/108 0/71 
3 5/179 (2.8) 1/178 (0.6) 0/168 
4 13/334 (3.9) 0/322 0/318 
    
Total 23/784 (2.9) 1/781 (0.1) 0/724 
 
Discussion 
Data from this study strongly suggests that MCFV’s are being maintained as 
subclinical infection in Tennessee cervid populations.  This is believed to be the 
first report of MCFV-WTD and OvHV-2 infection in white-tailed deer without 
clinical disease, as all previous reports were of deer that had died of apparent 
MCF disease (Kleiboeker et al., 2002; Li et al., 2000; Vikoren et al., 2006). 
MCFV-WTD and OvHV-2 are believe to be highly virulent in deer, therefore 
reports of infection in deer not related to disease are valuable in understanding 
the nature of MCF viruses in deer.  Although MCFV’s have typically been 
characterized as highly virulent in cattle, these hosts have also been shown to be 
susceptible to OvHV-2 infection without succumbing to disease (Taus et al., 
2006). Cattle are believed to be less susceptible to sheep-associated MCF than 
to wildebeest associated MCF (Loken et al., 2009).  Similar to cattle, deer may 
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be less susceptible to disease caused by MCFV-WTD, as more deer were 
detected with infection with this MCFV than any other strain in this study.  
The difference of prevalence reported in 2005 preliminary data (~30%) compared 
with this study could be related to several factors.  Data from 2005 came 
primarily from animals harvested in Eastern Tennessee.  During the hunting 
season of 2005, East Tennessee as well as the rest of the state experienced 
significant drought (Figure 2.2).  Drought could have led to higher stress in deer 
populations, making them more susceptible to infection.  Additionally, animals will 
have more contact with each other during drought as they congregate at 
common water and food sources, leading to increased transmission of 
pathogens.   
Another factor which may have influenced the prevalence (or lack thereof) of 
MCFV-WTD infection in 2007 and 2008 hunting seasons may have been an 
outbreak of epizootic hemorrhagic disease (EHD) prior to and during the 2007 
hunting season (Figure 2.3) (Hodge, 2007).  Infection with an MCFV could have 
made deer less resistant to infection with EHD, leading to increased mortality of 
MCFV infected deer and therefore a lower number of infected deer at the times 
of the survey.   
The presence of only one deer with OvHV-2 infection may be explained by 
reports that in deer this virus causes disease which is peracute or acute, and 





Figure 2.2 Departure From Normal Precipitation (inches) in East Tennessee 
During the 2005 Tennessee Deer Hunting Season                                              
(October 1, 2005 - December 31, 2005) 
Tennessee is highlighted by a black box.  This figure was adapted from the NOAA Southern Regional 






Figure 2.3 Severity of the 2007 EHD Outbreak in Tennessee Deer Populations 
 Figure taken from the 2009 Tennessee Hunting and Trapping Guide (TWRA, 2009) 
 
The lack of CpHV-2 infection in Tennessee cervid populations, particularly in, the 
largest area of goat production in the state (region 2) was surprising, as CpHV-2 
has been reported to cause chronic disease in cervids (Li et al., 2003b; Vikoren 
et al., 2006), and Tennessee is the second largest meat goat producing state in 
the U.S.  In a recent study (unpublished), prevalence of CpHV-2 in Tennessee 
goat herds was much lower than that reported in other studies (7% compared to  
73% of animals tested), which may explain the lack of CpHV-2 infection in 
Tennessee cervids.   
Studies to determine susceptibility of deer to MCFV-WTD are impeded due to the 
lack of evidence supporting a specific carrier animal for MCFV-WTD.  Without 
knowledge of a carrier animal, virus cannot be obtained to utilize in experimental 
infection studies, and naïve deer cannot be housed with a carrier animal to 
Severe (>10% Mortality) 
Moderate (5-10% Mortality) 
Insignificant (<5% Mortality) 
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investigate natural transmission.  Although goats are the known reservoir of 
CpHV-2, studies have not been performed to determine susceptibility of deer to 
this virus, and a method of isolating virus from goats for utilization in 
experimental transmission has not been established.   
Malignant catarrhal fever viruses are recognized to cause epizootics of high 
mortality in farmed deer (Brown and Bloss, 1992; Reid, 1991; Tomkins et al., 
1997), but more information needs to be obtained to determine if infection in free-
ranging cervids has as large an impact on the cervid population.  With an 
estimated population of 900,000 free-ranging deer in the state of Tennessee, an 
MCFV-WTD prevalence of 3% indicates that an estimated 27,000 deer may be 
latently infected with this virus.     
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Chapter 3. Caprine-Herpesvirus-2 Prevalence and Shedding 
Patterns in Tennessee Goat Herds 
 Abstract 
Virtually all domestic sheep are believed to become infected with OvHV-2.  The 
carrier status of CpHV-2 in goats has been estimated to be similar to that of 
OvHV-2 in sheep. Research was needed to confirm that CpHV-2 infection in 
goats is similar. In the summer of 2008, 3-5 mls of whole blood were taken from 
goats at nine Middle and East Tennessee goat farms selected based upon 
convenience of location.  Samples were analyzed for presence of caprine 
herpesvirus-2 DNA to estimate prevalence of this virus in Tennessee goat 
populations.  To investigate infection patterns, goats from a local petting zoo 
were routinely sampled every 2-3 weeks over a period of 3 months. Of the nine 
farms sampled, 3 had animals which tested positive to CpHV-2 DNA, with 
prevalence ranging from 7 to 17 percent.  Three of 15 petting zoo goats were 
shown to intermittently exhibit presence of viral DNA in blood samples obtained 
over the period of the study.  It appears that in general, prevalence of CpHV-2 in 
goats is lower than OvHV-2 in sheep, but recrudescence of viral infection of 
CpHV-2 in goats and OvHV-2 in sheep is similar.   
Introduction 
Goats have been suggested to be a source of malignant catarrhal fever virus 
where sheep and wildebeest were not present, but the agent of infection was 
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believed to be OvHV-2 (Li et al., 1996; Wiyono et al., 1994).   In 2001, a novel 
gammaherpesvirus in goats causing disease in cervid species was discovered 
and designated caprine herpesvirus-2 (CpHV-2) (Chmielewicz et al., 2001; Li et 
al., 2001b).  Similar to ovine herpesvirus-2 (OvHV-2) in sheep and alcelaphine 
herpesvirus-1 (AlHV-1) in wildebeest, the goat appears to be the carrier animal 
and infection with CpHV-2 does not cause recognized disease in goats. 
The infection and transmission pattern of this virus in goats has been estimated 
to be similar to that of OvHV-2 in sheep; virtually all animals are believed to be 
infected, and the young are not infected transplacentally, but are believed to be 
infected after 2 months of age.  In a previous study, prevalence of CpHV-2 
infection in goats sampled from multiple herds in several states was shown to be 
73 percent by PCR (Li et al., 2001b).  ( In this report, prevalence of CpHV-2 DNA 
was reported in 84% of seropositive animals, the value of 73% was obtained by 
dividing the total number of positive animals (n=104) by the total number of 
animals sampled, regardless of antibody status (n=142).   
Similar to OvHV-2 infection in sheep, when kids are separated from the herd at 
one week of age, they do not become infected with CpHV-2 virus (Li et al., 2005). 
Also, adult goats are susceptible to CpHV-2 when co-mingled with infected 
animals (Li et al., 2005).  Goats have been shown to be co-infected with CpHV-2 
as well as OvHV-2 (Li et al., 2001b; Li et al., 2005), but to date there have not 
been studies to show co-infection with these viruses in sheep. 
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Tennessee is the second highest producing state of meat goats in the United 
States (National Agriculture Statistics Service, 2002).  Although these animals 
are raised for meat purposes, does can be kept for many years for breeding 
purposes, therefore if infection with CpHV-2 is occurring in goat herds, it is 
believed the virus will persist on the farm.  To date there have been no surveys 
performed to determine CpHV-2 prevalence that have included goat herds in any 
of the southeastern states. Therefore this study was performed with the objective 
of investigating prevalence of CpHV-2 infection in Tennessee goat herds to 
determine if it is equivalent to that reported in goats in other states.  In addition to 
this, a second objective was to investigate the pattern of latent infection and 
circulation of viral DNA in the goats’ bloodstream, as little is known regarding 
infection patterns in goats.  To determine the pattern of infection and latency of 
CpHV-2 in goats, animals in a local petting zoo were sampled over a period of 3 
months to determine how often adult animals (>1 year of age) exhibited 
circulating viral DNA in the bloodstream when infected with CpHV-2.  Presence 
of circulating viral DNA in the blood was used as an indication of the animal’s 
ability to shed virus to other animals.   
Methods 
Animals and Sample Collection: Prevalence 
Nine goat producing farms were selected based upon convenience of 
location (primarily East Tennessee, and one Middle TN farm) and owner 
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willingness to participate in research studies at the University of 
Tennessee.  These farms included various breeds of domestic goats 
ranging in age, number and breed.  In the summer of 2008, 3-5mls of 
whole blood was collected from each goat at the farms (with the exception 
of farm D, where a portion of animals (n=150) selected by the farm 
manager were sampled, as there were over 400 goats on the farm) under 
a protocol approved by the University of Tennessee Institutional Animal 
Care and Use Committee (IACUC). This blood was stored in vacutainer 
tubes containing sodium heparin (BD Medical, Franklin Lakes, NJ) at 4 
degrees C until further processed. 
Animals and Sample Collection: Infection Patterns 
A group of animals from a local petting zoo including Nigerian Dwarf 
(n=15: 13 adults and 2 kids) and Oberhasli goats (n=2), as well as Tunis 
sheep (n=2) were sampled every 2-3 weeks for just over 3 months during 
the summer of 2008 (April 30-August 15).  The kids were added to the 
sampling protocol as they were born.  Whole blood, 3-5 mls., was 
collected from each animal under a protocol approved by the University of 
Tennessee IACUC.   This blood was stored in vacutainer tubes containing 




Sample Processing and Molecular Analysis 
DNA was extracted using the DNeasy blood and tissue kit according to the 
provided manufacture’s protocol (Qiagen, Valencia, CA).  Real-time PCR 
was performed according to the following protocol:  per each reaction: 2 
microliters extracted DNA, 10 microliters Taqman Universal PCR master 
Mix (Applied Biosystems, Foster City, CA) 0.4 microliters Rox Reference 
Dye II (Madison, WI), 0.9 microliters each of Forward and Reverse primer 
(F primer sequence: 5’- CAC TAC AAC ATC CTG TCC TT-3’ R primer 
sequence: 5’- AGG GTA AAG AAT GCA TAC AG -3’) 0.25 microliters 
Probe (P: 5’- 56-FAM/ AGA CGA AGA CAT AAT TAT CCA GAT ATC 
/3BHQ_1-3’) (IDT, Coralville, IA), and 7.55 microliters DNase RNase free 
water.  The reaction protocol is as follows: 50 degrees C for 30 seconds, 
90 degrees C for 10 minutes, then 42 cycles of: 95 degrees C for 15 
seconds, 50 degrees C for 1 minute, and 72 degrees C for 30 seconds.  
Samples were considered positive if amplification occurred above the 
baseline prior to cycle 40.  This assay targeted a conserved region of the 
CpHV-2 DNA polymerase gene. 
Statistical Analysis 
A two-sample test of proportion was performed in STATA to compare 
previously reported prevalence to prevalence obtained in this study to 
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determine if there was a significant difference (p<0.05) between the 
prevalence reported previously, and that reported in this study. 
Results 
Prevalence 
A total of 373 goats of various breed and age from nine Tennessee farms 
were sampled and tested by real-time PCR for presence of CpHV-2 DNA 
(Table 3.1).  All ages were included, although the majority of animals 
sampled were believed to be >1 year (actual age of every animal sampled 
was not known).  Of the animals with known age, a few were only a few 
weeks old, and others were as many as 12 years.  Overall prevalence of 
infection was 7% (26/373) (CI: 4-10%).  Of the nine farms, only farms C, 
F, and H had animals which tested positive for CpHV-2 DNA at the time of 
sampling.  Prevalence at these farms was 6.7%, 16.7% and 15.1% 
respectively.  Size of farm and breed of goat varied amongst the three 
farms.  Prevalence of CpHV-2 infection in goats was significantly lower 
than the previously reported 73 percent (P<0.0001).  
Infection and Recrudescence Patterns 
Samples were taken from 13 adult goats and 2 adult sheep at the petting 
zoo up to 8 times over the period of the study.  Three of the 13 adult goats 
were positive at different times over the period of the study, but were not 
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consistently positive every time sampled (Table 3.2).  One of the animals 
that had tested positive gave birth to a kid within the study period.  Both 
kids born during the study period were negative for CpHV-2 DNA within 
one week of birth, and remained negative through the end of the study (at 
the end of the study both kids were less than 2 months old).  Neither 
sheep tested positive for CpHV-2 at any time. 
 
Table 3.1 Prevalence of CpHV-2 in Domestic Goats from Middle and East 
Tennessee 
Blood samples were taken in the summer of 2008 from goats at Tennessee farms and molecular analysis 
was performed to determine prevalence of CpHV-2 in Tennessee goat herds. 
     *This farm also contained sheep, several cervid species, aoudads, and other exotic ruminants 
  
Farm Code County Breed(s) Pos/Tested (%) Date 
collected 
A Knox Saanen and Oberhasli 0/16 6/10/2008 
B Union Nigerian Dwarf 0/14 6/19/2008 
C Franklin Boer X and Nubian X 10/150(6.7) 7/22/2008 
D Knox Oberhasli and Lamancha 0/12 6/19/2008 
E* Knox Fainting and Pygmy 0/28 6/11/2008 and 7/23/2008 
F Cocke Saanen, Guernsey, and Nubian 8/48(16.7) 6/20/2008 
G Loudon Pygmy 0/6 6/10/2008 
H Knox Nubian X 8/53(15.1) 5/12/2008 







Table 3.2 Infection Patterns of CpHV-2 in a Petting Zoo 
CpHV-2 specific real-time PCR amplification was performed on whole blood samples from animals in a 
petting zoo containing goats infected with CpHV-2.    
 
Animal ID 4/30/08 5/14/08 5/28/08 6/11/08 6/25/08 7/9/08 7/23/08 8/15/08 
1 - - - + - - + ND 
2 - - - - - - - ND 
3 - - - - - - - ND 
4 + - + - - - + ND 
5 - - - - - - - ND 
6 - - - - - - - ND 
7*1 N/A N/A N/A N/A N/A - - - 
8 - - - - - - - ND 
9 + - - - - - + ND 
10 - - - - - - - ND 
11*2 N/A N/A N/A N/A N/A N/A - - 
12 - - - - - - - ND 
13 - - - - - - - - 
14 - - - - - - - ND 
15 - - - - - - - ND 
16*3 - - - - - - - ND 
17*3 - - - - - - - ND 
 
*1 Number 4’s kid  N/A: animal was not present at this time of the study 
*2 Number 13’s kid  ND: Sample was not taken 




Goats have been considered a source of MCF for many years, as they have 
been known to be subclinically infected with OvHV-2, and hypothesized to be 
able to spread that virus to other animals (Wiyono et al., 1994).  In the past 
decade, a novel gammaherpesvirus was discovered in goats and shown to cause 
disease in several cervid species (Chen et al., 2007; Crawford et al., 2002; Keel 
et al., 2003; Li et al., 2003b; Vikoren et al., 2006).  Many similarities have been 
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drawn between CpHV-2 in goats and OvHV-2 in sheep.  Sheep are believed to 
be ubiquitously infected with OvHV-2,  and in a previous study, it appeared the 
same was true for CPHV-2 in goats sampled from several different geographical 
locations (Arizona, California, Florida, Minnesota, New York, Ohio, Oregon, 
Washington and Alberta, Canada) and several breeds (Li et al., 2001b).  
However, prevalence of CpHV-2 infection in goats included in the current study 
(7 %) was significantly lower than the previously reported 73 percent.   It is 
unclear why there is such a dramatic divergence in prevalence between this 
study and previous reports. Sensitivity of the assay previously reported was 
reported to be 84%, but this number was obtained by dividing the number of PCR 
positive animals by the number of seropositive animals, therefore the actual 
sensitivity of this assay may be higher, as not all seropositive animals will have 
circulating viral DNA.  Seroprevalence of animals tested in this study was not 
determined, therefore it was not possible to perform a sensitivity calculation 
similar to that in the 2001 study. Relative sensitivity of the assay utilized in this 
report (based upon serial dilutions of a known copy number of a reference 
plasmid DNA) showed that the probe was able to detect as few as 13 copies of 
CpHV-2 viral DNA per reaction (data not shown). Relative sensitivity of the assay 
utilized in the 2001 study was not reported.  Perhaps the detection of CpHV-2 
DNA would have been increased by utilizing peripheral blood lymphocytes 
instead of whole blood for DNA extraction, as MCFV’s are believed to circulate in 
the lymphocytes of latently infected animals.  Samples were frozen immediately 
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after they were obtained which prevented collection of these cells for extraction.   
It was not possible to perform DNA extraction immediately upon collection.  
In this study, only herds with greater than 20 animals exhibited CpHV-2 infection.  
Stress has been shown to be instrumental in virus recrudescence.  It is possible 
that herds with higher numbers of animals may be more stressed due to herd 
dynamics and space limitations.    Animals tested at the petting zoo may have 
shown infection and recrudescence due to the stress of being located at the 
petting zoo, especially as traffic increases during the summer months, which was 
the study period.  Pregnancy did not appear to strongly induce viral 
recrudescence, as only one of the two pregnant goats exhibited viral infection 
over the course of the study, but further studies need to be performed to confirm 
this.  Neither kid born during the study had identifiable infection with CpHV-2, 
consistent with earlier reports that kids do not obtain virus transplacentally (Li et 
al., 2005).  This is important information for virus control, as it is possible to 
produce CpHV-2 free animals with proper management of the animals after birth.  
Many mixed species parks co-mingle goats and susceptible cervid species (roe, 
sika, moose, white-tailed deer, etc), and it is very important to be able to obtain 
virus free goats to maintain good health in a mixed species environment.  Further 
sampling of additional Tennessee goat herds, as well as additional sampling of 
animals in this study, may show higher prevalence of CpHV-2 overall, as adult 
goats were shown to intermittently have recrudescence of virus.  However, it 
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seems unlikely that prevalence would approach that previously reported, as it 
was ten times lower in this study.   
As goats have been shown to be co-infected with CpHV-2 and OvHV-2, another 
aspect of this study was to see if sheep were also able to be infected with both 
CpHV-2 and OvHV-2.  The sheep as well as the goats at this petting zoo have 
been sampled and tested routinely over the past several years for presence of 
OvHV-2.  Both sheep, as well as several of the adult goats, have shown previous 
OvHV-2 infection (data not shown, OvHV-2 DNA presence was not assessed at 
the time of this study).  In this study, sheep did not exhibit infection with CpHV-2 
at any time.  It may be possible that due to infection with OvHV-2, sheep are 
refractory or immune to infection with CpHV-2.  Further studies need to be 






Chapter 4. Malignant Catarrhal Fever Viruses in Cattle 
Populations: A Comparison of Healthy and Non-MCF 
Diseased Animals 
 Abstract 
Malignant catarrhal fever is a lymphoproliferative disease that affects many 
ruminant species.  Disease in North American cattle is most commonly 
associated with infection of OvHV-2, acquired by exposure to sheep.  To date no 
disease in cattle has been associated with MCF-WTD or CpHV-2.  We 
hypothesize that cattle may be infected with MCF viruses without succumbing to 
disease, and this infection may recrudesce when the animal becomes ill or 
debilitated due to complications other than MCF, contributing to the animal’s 
morbidity.  Blood samples from healthy or normal animals (n=156) were obtained 
from five healthy cattle herds and one slaughter facility, as well as animals 
(n=168) from 2 facilities which dispose of or screen dead and debilitated cattle to 
investigate the prevalence of MCFV infection.  Real-time PCR amplification 
revealed MCF viral DNA was present in 31 percent of samples from dead or 
debilitated cattle, in contrast to 1 percent of samples from healthy animals.   
Introduction 
Malignant catarrhal fever is a disease syndrome associated with a high fatality 
rate in many ruminant species, most commonly cattle, deer and especially bison.  
This disease is caused by a group of several gammaherpesviruses within the 
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rhadinovirus subgroup.  The strain of virus most commonly associated with 
disease in ruminants outside of the African continent is ovine herpesvirus-2, 
although both malignant catarrhal fever virus- white-tailed deer variant (MCFV-
WTD) and caprine herpesvirus-2 have been reported to cause disease in cervids 
(Chen et al., 2007; Crawford et al., 2002; Keel et al., 2003; Kleiboeker et al., 
2002; Li et al., 2000; Li et al., 2001b; Li et al., 2003b; Vikoren et al., 2006).  
Clinical signs vary depending on the species of animal infected, as well as the 
strain of virus causing disease (O'Toole and Li, 2008).   
In cattle, clinical signs of disease associated with OvHV-2 infection most 
commonly include corneal opacity, persistent fever, enlarged lymph nodes, 
mucosal ulceration, mucopurulent nasal and ocular discharge, diarrhea and 
hematuria (Pierson et al., 1979).  Sheep-associated MCF in cattle is most often 
fatal, although several cases have been reported where cattle have survived 
MCF following natural or experimental infection (Baxter et al., 1993; Hamilton, 
1990; Milne and Reid, 1990; O'Toole et al., 1995; Otter et al., 2002).  In other 
instances, OvHV-2 infection can occur in cattle without concurrent development 
of clinical MCF (Powers et al., 2005; Taus et al., 2006).   
Two other rhadinoviruses within the MCF subgroup known to cause disease in 
white-tailed deer and other cervid species, MCFV-WTD and CpHV-2, have not 
yet been documented to cause disease in cattle.   
Unlike alpha or beta herpes viruses, which seem to prefer lytic replication, 
gammaherpesviruses seem to favor the initial establishment of latency (Fields et 
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al., 2001).  This could explain why many animals are able to become infected 
with an MCFV without developing clinical disease.  According to a 2005 report, 
eight cattle from a dairy submitted for necropsy for reasons other than MCF had 
various diseases, but upon PCR analysis of tissue, 2 of the animals were positive 
for OvHV-2.   This dairy had a history of sheep-associated MCF outbreaks, and 
was located adjacent to a sheep feedlot.  Several animals at the dairy were 
positive for OvHV-2 without exhibiting any signs of clinical disease.  It may be 
possible that cattle develop a latent infection with a MCFV, and upon immuno-
suppression related to disease or injury, recrudescence of the virus occurs.   
The purpose of this study is to investigate if diseased or immunocompromised 
cattle exhibit a higher prevalence of infection with one or more of the gamma-
herpesviruses within the MCF group than do cattle in good health status. This 
was done by collecting blood samples from healthy cattle on several farms, as 
well as from two facilities that process dead or debilitated cattle for diagnosis 
and/or disposal.   Strain specific real-time PCR was performed to determine the 
prevalence of MCFV infection, and a comparison of the prevalence of MCFV’s in 
the two groups was performed to determine if there was a statistically significant 
difference.  This information may provide insight into the true nature of infection 
with MCFV’s in cattle, as the prevalence of subclinical infection in cattle with 
OvHV-2 has not been extensively investigated, and infection of cattle with CpHV-




Animals and Sample collection 
Healthy animals 
Six facilities were selected for this portion of the study based on 
accessibility and owner or manager’s willingness to participate in a 
research study.  Five of the facilities selected were UT Research 
and Education Centers (LD: dairy cattle, TN, FHB, AF and HR: beef 
cattle) with herds maintained by the University of Tennessee.  The 
sixth facility was a private East Tennessee slaughter facility.  
Samples were obtained from May 2006 to December 2007.  At the 
time of sampling, no animals with known MCF disease were 
identified within any of the herds.  Blood samples (3-5 mls.) were 
obtained from each animal under a protocol approved by the 
University of Tennessee Institutional Animal Care and Use 
Committee (IACUC). This blood was stored in vacutainer tubes 
containing sodium heparin (BD Medical, Franklin Lakes, NJ) at 4 
degrees C until further processed. 
Dead/debilitated animals 
Blood samples (3-5 mls.) from cattle submitted to the University of 
Tennessee Necropsy service (UTN) or to a regional (East 
Tennessee) contractor utilized by the USDA for bovine spongiform 
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encephalopathy surveillance were obtained for use in this portion of 
the study. Although lymph node, blood and brain samples were 
obtained from all animals in this category, blood samples were 
chosen for analysis to maintain consistency between the two 
sample groups.  Information regarding cause of death was not 
obtained for the majority of samples taken.  County of origin was 
recorded and this information was utilized in sample selection. 
Sample Processing  
DNA was extracted using the DNeasy blood and tissue kit according to the 
provided manufacture’s protocol (Qiagen, Valencia, CA).  DNA was stored 
at -20 degrees C for future use. 
Molecular Analysis 
Sample Selection 
Due to the large number of samples obtained during the course of 
this study, systematic sampling methods were employed to select 
samples for molecular analysis.  Samples were chosen based upon 





Real-time PCR was performed according to the following protocol:  
per each reaction: 2 microliters extracted DNA, 10 microliters 
Taqman Universal PCR master Mix (Applied Biosystems, Foster 
City, CA) 1 microliter of custom Taqman gene expression assay 
mix (Forward primer sequence: 5’- AGC AAA TAT GCC CAA CCC 
AGA TTA T-3’; Reverse primer sequence: 5’- GAG GCT AGC TTG 
TCG CTG AA-3’; Probe: 5’- 56-FAM/ AAT CGC CCC ACA CTA 
AC/3BHQ_1-3’) (Applied Biosystems, Foster, CA), and 7 microliters 
DNase RNase free water.  The reaction protocol is as follows: 50 
degrees C for 2 minutes, 90 degrees C for 10 minutes, then 40 
cycles of: 95 degrees C for 15 seconds, 60 degrees C for 1 minute.  
Samples were considered positive if amplification occurred above 
the baseline prior to cycle 40.  The target of this assay was a 
conserved region of the MCFV-WTD DNA polymerase gene.   
CpHV-2 
Real-time PCR was performed according to the following protocol:  
per each reaction: 2 microliters extracted DNA, 10 microliters 
Taqman Universal PCR master Mix (Applied Biosystems, Foster 
City, CA) 0.4 microliters Rox Reference Dye II (Madison, WI), 0.9 
microliters each of Forward and Reverse primer (F primer 
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sequence: 5’- CAC TAC AAC ATC CTG TCC TT-3’ R primer 
sequence: 5’- AGG GTA AAG AAT GCA TAC AG -3’) 0.25 
microliters Probe (P: 5’- 56-FAM/ AGA CGA AGA CAT AAT TAT 
CCA GAT ATC /3BHQ_1-3’) (IDT, Coralville, PA), and 7.55 
microliters DNase RNase free water.  The reaction protocol is as 
follows: 50 degrees C for 30 seconds, 90 degrees C for 10 minutes, 
then 42 cycles of: 95 degrees C for 15 seconds, 50 degrees C for 1 
minute, and 72 degrees C for 30 seconds.  Samples were 
considered positive if amplification occurred above the baseline 
prior to cycle 40.  The target of this assay was a conserved region 
of the CpHV-2 DNA polymerase gene. 
OvHV-2 
Real-time PCR was performed according to the following protocol:  
per each reaction: 2 microliters extracted DNA, 10 microliters 
Taqman Universal PCR master Mix (Applied Biosystems, Foster 
City, CA) 0.4 microliters Rox Reference Dye II (Madison, WI), 0.9 
microliters each of Forward and Reverse primer (F primer 
sequence: 5’- TGG TAG GAG CAG GCT ACC GT-3’ R primer 
sequence: 5’-ATC ATG CTG ACC CCT TGC AG-3’) 0.25 
microliters Probe (P: 5’- 56-FAM/TCC ACG CCG TCC GCA TAA 
GA/3BHQ_1-3’) (IDT, Coralville, PA), and 7.55 microliters DNase 
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RNase free water.  The reaction protocol is as follows: 50 degrees 
C for 30 seconds, 90 degrees C for 10 minutes, then 42 cycles of: 
95 degrees C for 15 seconds, 61 degrees C for 1 minute, and 72 
degrees C for 30 seconds.  Samples were considered positive if 
amplification occurred above the baseline prior to cycle 40.  The 
target of this assay was a non-functional tegument protein. 
Statistical Analysis 
A two-sample test of proportion was performed in STATA to compare 
MCFV prevalence in healthy cattle samples to those from dead or 
debilitated animals to determine if there was a significant difference 
(p<0.05) between the two groups. 
Results 
A total of 156 samples from 5 counties: Marshall (n=93), Cumberland (n=33), 
Greene (n=21), Union (n=7), and Robertson (n=2), were chosen for molecular 
analysis from healthy animals, and 168 from 26 counties (Table 4.1) were 
selected from dead/down cattle.  The majority of dead/debilitated cattle samples 
were obtained from 6 counties: Greene (n=50), Knox (n=22), Cocke (n=16), 
Sevier (n=14), Washington (n=14) and Jefferson (n=10).  MCFV DNA was 
detected in 1 percent (CI: 0-3%) (n=2/156) of healthy cattle. In contrast MCFV 
DNA was detected in 31 percent (CI: 30-44%) (n=52/168) of samples from 
dead/debilitated cattle.  Prevalence of MCFV DNA was significantly lower in 
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healthy cattle (1%) than in dead/debilitated cattle (31%) (p<0.0001). Thirteen 
percent (n=21/168) of dead/debilitated animals were positive for multiple 
MCFV’s, and 2 (1%) of these were positive for all three strains.  Individual 
percentages for each group and virus, as well as overall are listed in Table 4.2.   
The virus most prevalent in dead or debilitated animals was MCFV-WTD (27%), 
followed by OvHV-2 (15%), then CpHV-2 (3%).  The only viral DNA detected in 
healthy animal samples was MCFV-WTD.  No CpHV-2 or OvHV-2 DNA was 
detected in animals in good health.   
 
Table 4.1 Location by County of Samples Obtained From Dead/Debilitated 
Animals 
Every third sample obtained in each county was processed and utilized for detection of MCFV 
prevalence.  Samples came from University of Tennessee necropsy services, as well as a local facility 




Samples Analyzed County 
Number of 
Samples Analyzed County 
Number of 
Samples Analyzed 
Anderson 1 Greene 50 Monroe 2 
Bledsoe 1 Hamblen 3 Roane 1 
Blount 2 Hamilton 1 Scott 1 
Carter 1 Hancock 1 Sevier 14 
Claiborne 4 Hawkins 8 Sullivan 3 
Cocke 16 Jefferson 10 Union 2 
Cumberland 1 Knox 22 Washington 14 
Fentress 1 Loudon 3 Williamson 1 
Grainger 4 Meigs 1 
  Total number of samples: 







Table 4.2 Prevalence of MCFV-WTD, CpHV-2, and/or OvHV-2 DNA in Healthy and 
Dead/Debilitated Animals 
Real-time PCR amplification was performed on samples from various facilities and percent infected 
animals was reported based on health status. 
 
Sample site Health Status MCFV-WTD CpHV-2 OvHV-2 
  
Pos/tested (%) Pos/tested (%) Pos/tested (%) 
AF Healthy 0/21 0/21 0/21 
ANA Healthy 0/7 0/7 0/7 
FHB Healthy 0/5 0/5 0/1 
HR Healthy 0/2 0/2 0/1 
LD Healthy 2/93 (2) 0/93 0/93 
TN Healthy 0/28 0/28 0/28 
Total Healthy 2/156(1) 0/156 0/151 
     
BSE*1 Dead/Debilitated 38/113 (34) 3/113(3) 22/113 (20) 
UTN*2 Dead/Debilitated 7/55 (13) 2/55 (4) 3/55 (5) 
Total 
Dead/Debilitated  
45/166 (27) 5/168 (3) 25/165(15) 
     
Total 
 
47/322 (15) 5/324 (1) 25/316 (8) 
     *1 Disposal and screening facility, samples from multiple farms in 14 counties 
*2 University of Tennessee Necropsy service, samples from multiple farms in 22 counties 
 
Due to the surprisingly high prevalence of MCFV-WTD DNA detected in this 
study (27%), amplification product of a subset of samples (n=5) were sequenced 
by the University of Tennessee Biology Resource Facility to confirm that cross-
reactivity was not occurring with any other bovine herpesvirus.  All 5 assay 
positive samples (4 from dead or debilitated cattle, as well as one from the 
healthy cattle herd) exhibited 96-98% identity with the MCFV-WTD DNA 




Infection of cattle with OvHV-2 has been shown to occur without development of 
sheep-associated MCF syndrome (Powers et al., 2005; Taus et al., 2006).   In 
addition to infection without disease, recovery from sheep-associated MCF has 
been reported, and cattle that have recovered from infection with OvHV-2 have 
been demonstrated to remain positive by PCR for the virus for up to 24 months 
(O'Toole et al., 1997).  In a previous study, in healthy cattle herds that had 
experienced an outbreak of sheep-associated MCF within the previous 5 years, 
OvHV-2 DNA was present in blood samples from 4 percent (n=15 /360) of cattle 
surveyed (Loken et al., 2009).  Based upon this information, the 15 percent 
prevalence of OvHV-2 DNA (n=25/165) in dead/debilitated cattle could be 
explained by previous undiagnosed outbreaks in the herds from which these 
animals were submitted.  Unfortunately parameters under which the study was 
set up did not allow identification/contact with the owners/herd managers of 
positive cases.     
This is the first report of infection of cattle with MCFV-WTD.  In this study, 27% 
prevalence of MCFV-WTD was recorded in dead/debilitated cattle.  In a 2005 
study performed in East Tennessee cervids, a similar prevalence (>30%) was 
recorded in presumed healthy harvested deer, followed by a decreased 
prevalence (3%) of MCFV-WTD in deer in 2006.  It may be possible an outbreak 
of this virus occurred in ruminants in the region in 2005, without development of 
MCF symptoms.  If cattle were infected with the virus, and did not become 
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diseased, they may have maintained a latent infection for several months 
following infection, similar to that reported with OvHV-2 infection, explaining 
infection at the time of sampling.  Another explanation for the high prevalence of 
MCFV-WTD infection in dead/debilitated cattle is that viruses can recrudesce 
when animals are undergoing periods of high stress (infection with another 
pathogen, injury, overcrowding, heat stress, etc).  If animals were infected in 
previous years with an MCFV, recrudescence may have occurred prior to death.   
This is also the first report of CpHV-2 infection in cattle.  Prevalence of CpHV-2 
infection in goat herds is lower in Tennessee (7%) than that reported in previous 
studies of CpHV-2 in goats (73%)(Li et al., 2001b), which may explain why the 
prevalence (3%, n=5/168) of this MCFV was not as high in the dead/debilitated 
cattle as that reported for other strains.   
Further studies need to be performed to determine the impact MCFV-WTD and 
CpHV-2 may have on cattle populations and herd health.  The carrier animal is 
unknown for MCFV-WTD, therefore it is not possible to attempt natural 
transmission of virus to cattle in a controlled setting.  Natural transmission of 
CpHV-2 to cattle from an infected goat has not been attempted.  Also, there is no 
known method of growing MCFV-WTD or CpHV-2 in vitro for use in experiment 
infection studies, therefore studies of these viruses and their effect on cattle 





Chapter 5. Discussion and Conclusions 
 
Multiple Malignant catarrhal fever viruses are present in several species of ruminants 
throughout the state of Tennessee.  Occurrence of disease related to MCFV infection in 
Tennessee is presumed to be similar to that in Europe and other American states.  Its 
incidence is sporadic and it is most commonly associated with exposure to infected 
sheep.  Disease related to infection with MCFV-WTD and CpHV-2 has not been 
reported in Tennessee cattle or cervid populations.   
This study demonstrated that healthy cattle and cervids can be infected with OvHV-2 
and MCFV-WTD without apparent disease, and that dead or debilitated cattle were 
infected with CpHV-2.  The previously unreported discovery of infection in cattle with 
CpHV-2 MCFV-WTD opens a new avenue of investigation into the pathology and 
virulence of MCFV’s in domestic cattle.  Perhaps infection of cattle with CpHV-2 or 
MCFV-WTD causes a previously unrecognized pattern of disease in this species.    
Based on the discovery of MCFV infection without concurrent signs of disease in cattle 
and deer, fatality rates related to infection with an MCFV may be much lower than 
previous estimates, especially in white-tailed deer (Brown and Bloss, 1992; Kleiboeker 
et al., 2002; Li et al., 2000; Otter et al., 2002).  The prevalence of MCFV infection in 
dead or debilitated cattle was significantly higher than that in healthy cattle, which may 
provide some additional insight into the pathology of infection in cattle. The findings of 
co-infection of dead and debilitated cattle with multiple MCF viruses raises the 
possibility of long-term sub-clinical infection as it seems unlikely that the cattle 
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contracted the viruses simultaneously or from another single point source.  It appears 
likely that MCFV’s, like other herpes viruses, may recrudesce when cattle are in poor 
health.  While it is tempting to speculate, additional information is needed to determine if 
infection with one or more of the MCFV viruses increases morbidity in cattle when 
experiencing co-infection with another unrelated pathogen.   
 The prevalence of CpHV-2 in goats is much lower in Tennessee than has been reported 
previously in other areas of the US (Li et al., 2001b).  Perhaps the detection of CpHV-2 
DNA would have been increased by utilizing peripheral blood lymphocytes instead of 
whole blood for DNA extraction, as MCFV’s are believed to circulate in the lymphocytes 
of latently infected animals.  Blood samples were frozen immediately after they were 
obtained which prevented collection of these cells for extraction.  Due to time 
constraints and limited personnel, it was not possible to perform DNA extraction 
immediately upon collection.  
Low prevalence of CpHV-2 in Tennessee goat populations likely explains why no 
evidence of infection was found in any of the cervids tested, and the low prevalence of 
CpHV-2 infection in dead or debilitated cattle compared to the rates of infection for 
OvHV-2 and MCFV-WTD.  Additionally, cattle may be less susceptible to infection with 
CpHV-2 than other MCFV’s. 
While roughly equivalent percentages of the goat and deer populations were infected 
with CpHV-2 and MCFV-WTD respectively, and CpHV-2 infection was identified in a 
bovine, it is interesting that a much higher percentage of dead and debilitated cattle had 
evidence of MCFV-WTD than CpHV-2.  Again, while it is tempting to speculate, more 
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detailed studies regarding the interface of cattle and deer versus cattle and goats are 
necessary to elucidate the reason for this divergence.      
One of the underlying reasons for this study was to determine if deer were a source of 
OvHV-2 infection in cattle.  OvHV-2 was identified in Tennessee deer but at a low 
prevalence.  At the recognized level of infection within “healthy” animals it is difficult to 
ascribe a meaningful role to deer as a source of infection in cattle unless infected deer 
rapidly succumb and were not available for testing.  Acquiring samples from diseased 
wild deer with known naïve cattle contact presents incredible difficult challenge.  
No vaccines are available for prevention of MCFV infection.  The primary method to 
control spread of disease is to prevent contact between carriers and clinically 
susceptible species.  Studies have shown that it is possible to obtain OvHV-2 free 
lambs and CpHV-2 free kids if they are removed from infected herds in a timely matter 
(prior to 3 months for lambs, prior to nursing for kids) (Li et al., 2005; Li et al., 1998).  
There is no known method to control infection of MCFV-WTD, as the carrier animal of 
this virus is unknown.  Information is needed regarding the pathology of this virus in 
free-ranging white-tailed deer as well as other ruminants to determine if MCFV-WTD 
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